These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 23767972)

  • 1. High levels of anti-inflammatory and pro-resolving lipid mediators lipoxins and resolvins and declining docosahexaenoic acid levels in human milk during the first month of lactation.
    Weiss GA; Troxler H; Klinke G; Rogler D; Braegger C; Hersberger M
    Lipids Health Dis; 2013 Jun; 12():89. PubMed ID: 23767972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long chain fatty acids and related pro-inflammatory, specialized pro-resolving lipid mediators and their intermediates in preterm human milk during the first month of lactation.
    Robinson DT; Palac HL; Baillif V; Van Goethem E; Dubourdeau M; Van Horn L; Martin CR
    Prostaglandins Leukot Essent Fatty Acids; 2017 Jun; 121():1-6. PubMed ID: 28651692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of inflammatory and proresolving lipid mediators in bone marrow and their lipidomic profiles with ovariectomy and omega-3 intake.
    Poulsen RC; Gotlinger KH; Serhan CN; Kruger MC
    Am J Hematol; 2008 Jun; 83(6):437-45. PubMed ID: 18429055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative profiling of inflammatory and pro-resolving lipid mediators in human adolescents and mouse plasma using UHPLC-MS/MS.
    Hartling I; Cremonesi A; Osuna E; Lou PH; Lucchinetti E; Zaugg M; Hersberger M
    Clin Chem Lab Med; 2021 Oct; 59(11):1811-1823. PubMed ID: 34243224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formation of lipoxins and resolvins in human leukocytes.
    Kahnt AS; Schebb NH; Steinhilber D
    Prostaglandins Other Lipid Mediat; 2023 Jun; 166():106726. PubMed ID: 36878381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low levels of pro-resolving lipid mediators lipoxin-A4, resolvin-D1 and resolvin-E1 in patients with rheumatoid arthritis.
    Özgül Özdemir RB; Soysal Gündüz Ö; Özdemir AT; Akgül Ö
    Immunol Lett; 2020 Nov; 227():34-40. PubMed ID: 32818598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regression of human coronary artery plaque is associated with a high ratio of (18-hydroxy-eicosapentaenoic acid + resolvin E1) to leukotriene B
    Welty FK; Schulte F; Alfaddagh A; Elajami TK; Bistrian BR; Hardt M
    FASEB J; 2021 Apr; 35(4):e21448. PubMed ID: 33749913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of specialized pro-resolving mediator clusters from healthy adults after intravenous low-dose endotoxin and omega-3 supplementation: a methodological validation.
    Norris PC; Skulas-Ray AC; Riley I; Richter CK; Kris-Etherton PM; Jensen GL; Serhan CN; Maddipati KR
    Sci Rep; 2018 Dec; 8(1):18050. PubMed ID: 30575798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-angiogenesis effect of the novel anti-inflammatory and pro-resolving lipid mediators.
    Jin Y; Arita M; Zhang Q; Saban DR; Chauhan SK; Chiang N; Serhan CN; Dana R
    Invest Ophthalmol Vis Sci; 2009 Oct; 50(10):4743-52. PubMed ID: 19407006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-Chain Polyunsaturated Fatty Acids (LCPUFAs) and the Developing Immune System: A Narrative Review.
    Miles EA; Childs CE; Calder PC
    Nutrients; 2021 Jan; 13(1):. PubMed ID: 33467123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The need for precision nutrition, genetic variation and resolution in Covid-19 patients.
    Simopoulos AP; Serhan CN; Bazinet RP
    Mol Aspects Med; 2021 Feb; 77():100943. PubMed ID: 33551236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipoxins and new lipid mediators in the resolution of inflammation.
    Schwab JM; Serhan CN
    Curr Opin Pharmacol; 2006 Aug; 6(4):414-20. PubMed ID: 16750421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of fish oil supplementation in pregnancy on breast milk fatty acid composition over the course of lactation: a randomized controlled trial.
    Dunstan JA; Mitoulas LR; Dixon G; Doherty DA; Hartmann PE; Simmer K; Prescott SL
    Pediatr Res; 2007 Dec; 62(6):689-94. PubMed ID: 17957152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Temporal Progression of Fatty Acids in Preterm and Term Human Milk of Mothers from Switzerland.
    Thakkar SK; De Castro CA; Beauport L; Tolsa JF; Fischer Fumeaux CJ; Affolter M; Giuffrida F
    Nutrients; 2019 Jan; 11(1):. PubMed ID: 30626044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resolution of inflammation in neuromyelitis optica spectrum disorders.
    Wang X; Jiao W; Lin M; Lu C; Liu C; Wang Y; Ma D; Wang X; Yin P; Feng J; Zhu J; Zhu M
    Mult Scler Relat Disord; 2019 Jan; 27():34-41. PubMed ID: 30300851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipidomic profiling of bioactive lipids by mass spectrometry during microbial infections.
    Tam VC
    Semin Immunol; 2013 Oct; 25(3):240-8. PubMed ID: 24084369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytokine distribution in mothers and breastfed children after omega-3 LCPUFAs supplementation during the last trimester of pregnancy and the lactation period: A randomized, controlled trial.
    Rodriguez-Santana Y; Ochoa JJ; Lara-Villoslada F; Kajarabille N; Saavedra-Santana P; Hurtado JA; Peña M; Diaz-Castro J; Sebastian-Garcia I; Machin-Martin E; Villanueva M; Ramirez-Garcia O; Peña-Quintana L
    Prostaglandins Leukot Essent Fatty Acids; 2017 Nov; 126():32-38. PubMed ID: 29031393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human inflammatory and resolving lipid mediator responses to resistance exercise and ibuprofen treatment.
    Markworth JF; Vella L; Lingard BS; Tull DL; Rupasinghe TW; Sinclair AJ; Maddipati KR; Cameron-Smith D
    Am J Physiol Regul Integr Comp Physiol; 2013 Dec; 305(11):R1281-96. PubMed ID: 24089379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipid profiling reveals the presence of unique lipid mediators in human milk from healthy and mastitic subjects.
    Nagasaki Y; Kawai E; Maruoka S; Osumi M; Tsukayama I; Kawakami Y; Takahashi Y; Okazaki Y; Miki Y; Taketomi Y; Yamamoto K; Murakami M; Suzuki-Yamamoto T
    Biochem Biophys Res Commun; 2022 Nov; 630():84-91. PubMed ID: 36152349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pro-resolving lipid mediator Resolvin D1 serves as a marker of lung disease in cystic fibrosis.
    Eickmeier O; Fussbroich D; Mueller K; Serve F; Smaczny C; Zielen S; Schubert R
    PLoS One; 2017; 12(2):e0171249. PubMed ID: 28158236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.